Published in Rev Prat on September 01, 2012
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol (2012) 3.88
Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol (2005) 2.37
Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma. Pediatr Blood Cancer (2009) 2.32
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum (2003) 2.03
Hypothalamic-pituitary lesions in pediatric patients: endocrine symptoms often precede neuro-ophthalmic presenting symptoms. J Pediatr (2012) 2.02
Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Am J Hum Genet (2004) 1.98
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain (2003) 1.85
A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer (2006) 1.76
Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood (2011) 1.71
Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience. Cancer (2005) 1.67
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer (2008) 1.48
Children's views on their involvement in clinical research. Pediatr Blood Cancer (2008) 1.47
Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. J Clin Endocrinol Metab (2004) 1.46
Retinoblastoma. Orphanet J Rare Dis (2006) 1.44
Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy. Pediatr Blood Cancer (2013) 1.43
2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. Pediatr Blood Cancer (2009) 1.39
Accumulation of segmental alterations determines progression in neuroblastoma. J Clin Oncol (2010) 1.36
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35
Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. Cancer (2011) 1.34
Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol (2003) 1.33
SWI/SNF chromatin remodeling and human malignancies. Annu Rev Pathol (2014) 1.27
Genotype-phenotype correlations in hereditary familial retinoblastoma. Hum Mutat (2007) 1.25
Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res (2011) 1.24
Brainstem gliomas in children and adults. Curr Opin Oncol (2008) 1.23
The readability of information and consent forms in clinical research in France. PLoS One (2010) 1.19
Chemothermotherapy in the management of retinoblastoma. Ophthalmology (2002) 1.16
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol. J Clin Oncol (2005) 1.13
Neonatal cancer. Lancet Oncol (2013) 1.13
Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer (2005) 1.12
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathol (2013) 1.12
Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med (2009) 1.12
Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors. AIDS (2008) 1.11
Hypothalamic dysfunction associated with neuroblastoma: evidence for a new Paraneoplastic syndrome? Med Pediatr Oncol (2003) 1.10
Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma. Cancer Res (2012) 1.09
Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie. Eur J Cancer (2004) 1.08
Conservative treatments of intraocular retinoblastoma. Ophthalmology (2008) 1.04
Gastric inflammatory myofibroblastic tumors in children: an unpredictable course. J Pediatr Gastroenterol Nutr (2002) 1.02
Specific TP53 mutation pattern in radiation-induced sarcomas. Carcinogenesis (2006) 0.99
Presentation and evolution of organic central precocious puberty according to the type of CNS lesion. Clin Endocrinol (Oxf) (2006) 0.97
Role of chemotherapy resistance genes in outcome of neuroblastoma. Pediatr Blood Cancer (2007) 0.96
Functional results after treatment of retinoblastoma. J AAPOS (2002) 0.95
A deep intronic mutation in the RB1 gene leads to intronic sequence exonisation. Eur J Hum Genet (2007) 0.93
Birth characteristics and childhood malignant central nervous sytem tumors: the ESCALE study (French Society for Childhood Cancer). Cancer Detect Prev (2008) 0.91
Involvement of the TGFβ pathway in the regulation of α5 β1 integrins by caveolin-1 in human glioblastoma. Int J Cancer (2011) 0.91
VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l'Enfant (SFCE). Pediatr Blood Cancer (2009) 0.91
A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults' trials. Eur J Cancer (2013) 0.90
Fertility treatments, congenital malformations, fetal loss, and childhood acute leukemia: the ESCALE study (SFCE). Pediatr Blood Cancer (2012) 0.90
Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE). Cancer Causes Control (2012) 0.89
Diencephalic syndrome due to hypothalamic tumor: a model of the relationship between weight and puberty onset. J Clin Endocrinol Metab (2006) 0.89
Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities. Blood (2011) 0.88
Embryonal tumor with multilayered rosettes: diagnostic tools update and review of the literature. Clin Neuropathol (2013) 0.87
Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: toxicity and efficacy trends. Pediatr Blood Cancer (2012) 0.87
Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndrome. Horm Res Paediatr (2014) 0.87
Effect of adapted physical activity sessions in the hospital on health-related quality of life for children with cancer: a cross-over randomized trial. Pediatr Blood Cancer (2010) 0.86
Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain. Oncogene (2005) 0.86
Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activation. Neuro Oncol (2011) 0.86
Readability of the written study information in pediatric research in France. PLoS One (2011) 0.85
Five new cases of juvenile renal cell carcinoma with translocations involving Xp11.2: a cytogenetic and morphologic study. Cancer Genet Cytogenet (2003) 0.85
Proteasome inhibition by bortezomib does not translate into efficacy on two malignant glioma xenografts. Oncol Rep (2008) 0.85
Focus on invasive mucormycosis in paediatric haematology oncology patients: a series of 11 cases. Mycoses (2012) 0.84
Extracranial rhabdoid tumours: what we have learned so far and future directions. Lancet Oncol (2013) 0.84
Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study. BMJ Open (2013) 0.84
MYC and MYCN amplification can be reliably assessed by aCGH in medulloblastoma. Cancer Genet (2013) 0.84
A French cohort of childhood leukemia survivors: impact of hematopoietic stem cell transplantation on health status and quality of life. Biol Blood Marrow Transplant (2013) 0.84
Fertility and pregnancy outcome after abdominal irradiation that included or excluded the pelvis in childhood tumor survivors. Int J Radiat Oncol Biol Phys (2009) 0.84
Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignancies. J Clin Oncol (2008) 0.84
Shall we treat hydrocephalus associated to brain stem glioma in children? Childs Nerv Syst (2011) 0.84
Neuropathological and neuroradiological spectrum of pediatric malignant gliomas: correlation with outcome. Neurosurgery (2011) 0.84
Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas. Cancer Genet Cytogenet (2002) 0.83
Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy and childhood malignant central nervous system tumours: the ESCALE study (SFCE). Eur J Cancer Prev (2008) 0.83
Low bone mineral density and high incidences of fractures and vitamin D deficiency in 52 pediatric cancer survivors. Horm Res Paediatr (2010) 0.83
Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts. Int J Radiat Oncol Biol Phys (2004) 0.83
SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries. Pediatr Blood Cancer (2013) 0.83
PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors. Am J Surg Pathol (2012) 0.82
Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study. Eur J Pediatr (2011) 0.82
Growth deceleration in children treated with imatinib for chronic myeloid leukaemia. Eur J Cancer (2014) 0.82
Weight-based strategy of dose administration in children using intravenous busulfan: clinical and pharmacokinetic results. Pediatr Blood Cancer (2011) 0.82
Measurement of hypoxia using invasive oxygen-sensitive electrode, pimonidazole binding and 18F-FDG uptake in anaemic or erythropoietin-treated mice bearing human glioma xenografts. Int J Oncol (2008) 0.82
Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation. J Clin Oncol (2013) 0.81
Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison. Pediatr Radiol (2007) 0.81
In vivo efficacy of photodynamic therapy in three new xenograft models of human retinoblastoma. Photodiagnosis Photodyn Ther (2010) 0.81
Fine-needle aspiration as a diagnostic technique in 50 cases of primary Ewing sarcoma/peripheral neuroectodermal tumor. Institut Curie's experience. Diagn Cytopathol (2010) 0.80
SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors? Am J Surg Pathol (2012) 0.80
Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood. Haematologica (2013) 0.80
Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009. Orphanet J Rare Dis (2010) 0.80
[Retinoblastoma: inventory in Mali and program to develop early diagnosis, treatments and rehabilitation]. Bull Cancer (2013) 0.79
Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma. Eur J Cancer (2007) 0.79
Chemotherapy for children with medulloblastoma. Cochrane Database Syst Rev (2015) 0.79
Inhibin B and anti-Müllerian hormone as markers of gonadal function after treatment for medulloblastoma or posterior fossa ependymoma during childhood. J Pediatr (2010) 0.79
Is it pre-enucleation chemotherapy or delayed enucleation of severely involved eyes with intraocular retinoblastoma that risks extraocular dissemination and death? J Clin Oncol (2011) 0.79
Drug-drug interaction between methotrexate and levetiracetam in a child treated for acute lymphoblastic leukemia. Pediatr Blood Cancer (2012) 0.79
Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas. Eur J Hum Genet (2012) 0.78